Non-Contrast MR Imaging: CSF Flow and Multi-Phase Procedures

On-Demand Webcast

On-Demand Webcast


Sponsored by North American Center for Continuing Medical Education, LLC

Presenters

David J. McFadden, MD
Radiology
Washington Hospital Center
Washington, DC

Meng Law, MD, MBBS, FRACR
Professor of Radiology and Neurological Surgery
Director of Neuroradiology
Keck School of Medicine
University of Southern California
Los Angeles, California

Intended Learners

This activity is designed for interventional radiologists, neurologists, neurosurgeons, interventional neuroradiologists, interventional cardiologists, radiologic technologists, physicists, administrators, and related healthcare professionals.

Learning Objectives

After completing this activity, participants should be able to:

  • Outline the normal neuroanatomy, cerebrospinal fluid (CSF) flow, and techniques for characterizing CSF flow
  • Discuss the impact of nephrogenic systemic fibrosis on neurological imaging
  • Compare and contrast the benefits and limitations of traditional and emerging non-contrast sequences

Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 20-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: November 23, 2011
Expiration Date: November 23, 2012
Estimated time to complete: 1 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME

NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AHRA Accreditation

Approved for 1 ARRT Category A CE credit by AHRA.

Independent Clinical Reviewer: Darin T. Okuda, MD, Assistant Clinical Professor of Neurology, UCSF Multiple Sclerosis Center, San Francisco, California.

Planning Committee

The planning committee comprises David J. McFadden, MD, Meng Law, MD, MBBS, FRACR, Darin Okuda, MD; and Diane Borges, PhD, Kristin Ciszeski, Mike Kearney, Rich Keenan, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are indentified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Law: Grant/research support—Accelerate Brain Cancer Cure, Bayer Healthcare; Consultant—Bracco Diagnostics, Inc; Scientific advisor—iCAD Imaging, Inc, Siemens Healthcare; Promotional speakers bureau—Toshiba America Medical Systems, Inc; Stock shareholder—Prism Clinical Imaging, Inc
Dr. McFadden and Dr. Okuda have disclosed no relevant financial relationships with any commercial interests

Dr. Borges, Ms. Ciszeski, Mr. Kearney, Mr. Keenan, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed no off-label/unapproved uses of drugs and/or devices that will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2011 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Toshiba America Medical Systems, Inc.

  • Start Date: November 23, 2011
  • End Date: November 23, 2012
    • 1.00 AHRA
    • 1.00 CME
  • Therapeutic Area:
    • Cardiology
    • Neurology